HCA HR chief granted 6,206 stock appreciation rights

HCA Healthcare SVP & Chief Human Resources Officer Jennifer Berres received a grant of 6,206 stock appreciation rights on common stock.

Rhea-AI Filing Summary

HCA Healthcare SVP & Chief Human Resources Officer Jennifer Berres received a grant of 6,206 stock appreciation rights on common stock. The rights have an exercise price of $482.53 and were awarded on January 29, 2026. All 6,206 derivative securities are held as direct ownership.

The stock appreciation rights vest in four equal annual installments beginning on January 29, 2027, and expire on January 29, 2036. This grant represents equity-based compensation that ties part of the executive’s potential future value to HCA Healthcare’s share price performance over time.

Insider Trade Summary

Grant/Award: 6,206 shares

Grant/Award 1 txn

Insider Berres Jennifer

Role SVP & Chief Human Res. Officer

Type	Security	Shares	Price	Value
Grant/Award	Stock Appreciation Right	6,206	$0.00	$0.00

Holdings After Transaction: Stock Appreciation Right — 6,206 contracts (Direct)

Footnotes (1)

1. F1. The stock appreciation rights vest in four equal annual installments beginning on January 29, 2027.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did HCA (HCA) executive Jennifer Berres report in this Form 4 filing?

Jennifer Berres reported receiving 6,206 stock appreciation rights on HCA common stock. The award was granted on January 29, 2026, at an exercise price of $482.53 per share and is held directly as part of her equity compensation package.

How many stock appreciation rights did HCA executive Jennifer Berres receive?

Jennifer Berres received 6,206 stock appreciation rights tied to HCA common stock. All 6,206 derivative securities are shown as beneficially owned following the transaction, reflecting the full size of this equity-based compensation grant reported in the Form 4.

What is the exercise price of Jennifer Berres’s HCA stock appreciation rights?

The stock appreciation rights granted to Jennifer Berres have an exercise price of $482.53 per share. This price is the reference level above which any appreciation in HCA common stock could generate value for the executive under the terms of the award.

When do Jennifer Berres’s HCA stock appreciation rights vest?

The stock appreciation rights vest in four equal annual installments beginning on January 29, 2027. This means the grant becomes exercisable gradually over four years, aligning the executive’s potential benefit with longer-term company and share price performance.

When do the HCA stock appreciation rights granted to Jennifer Berres expire?

The stock appreciation rights granted to Jennifer Berres expire on January 29, 2036. This expiration date sets the outer limit for when the rights can be exercised after they vest, providing a long-term incentive horizon tied to HCA’s stock performance.

Is Jennifer Berres’s ownership of these HCA stock appreciation rights direct or indirect?

Jennifer Berres holds the 6,206 stock appreciation rights as direct beneficial ownership. The Form 4 identifies the ownership form as direct, and no footnotes indicate that another entity or person holds voting or investment authority over these derivative securities.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/02/2026 - 06:42 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Berres Jennifer

(Last) (First) (Middle)

ONE PARK PLAZA

(Street)

NASHVILLE TN 37203

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
HCA Healthcare, Inc. [ HCA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP & Chief Human Res. Officer

3. Date of Earliest Transaction (Month/Day/Year)
01/29/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Appreciation Right	$482.53	01/29/2026		A		6,206		01/29/2027(1)	01/29/2036	Common Stock	6,206	$0	6,206	D

Explanation of Responses:

1. The stock appreciation rights vest in four equal annual installments beginning on January 29, 2027.

	/s/ Kevin A. Ball, Attorney-in-Fact	02/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.